During the past decade, Michigan State University Clinical Center conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 43 clinical trials were completed, i.e. on average, 89.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 24 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michigan State University Clinical Center" #1 sponsor was "Children's Oncology Group" with 56 trials, followed by "National Cancer Institute (NCI)" with 43 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "LLS PedAL Initiative, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan State University Clinical Center" #1 collaborator was "National Cancer Institute (NCI)" with 62 trials as a collaborator, "Children's Oncology Group" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Michigan State University Clinical Center" are "Recurrent Neuroblastoma" (12 trials), "Refractory Neuroblastoma" (9 trials), "Recurrent Hepatoblastoma" (8 trials), "Recurrent Langerhans Cell Histiocytosis" (8 trials) and "Recurrent Malignant Solid Neoplasm" (8 trials). Many other conditions were trialed in "Michigan State University Clinical Center" in a lesser frequency.

Most popular intervention types in "Michigan State University Clinical Center" are "Drug" (81 trials), "Other" (76 trials), "Biological" (39 trials), "Procedure" (37 trials) and "Radiation" (32 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (49 trials), "Cyclophosphamide" (36 trials), "Vincristine Sulfate" (31 trials), "Etoposide" (25 trials) and "Doxorubicin Hydrochloride" (24 trials). Other intervention names were less common.

The vast majority of trials in "Michigan State University Clinical Center" are 100 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Michigan State University Clinical Center". undefined are not yet recruiting, 30 are recruiting, 51 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Michigan State University Clinical Center, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Michigan State University Clinical Center, 0 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".